These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 22329717

  • 21. Targeted deletion in the beta20-beta21 loop of HIV envelope glycoprotein gp120 exposes the CD4 binding site for antibody binding.
    Berkower I, Patel C, Ni Y, Virnik K, Xiang Z, Spadaccini A.
    Virology; 2008 Aug 01; 377(2):330-8. PubMed ID: 18519142
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Importance of conformation on the neutralizing antibody response to HIV-1 gp120.
    Steimer KS, Haigwood NL.
    Biotechnol Ther; 1991 Aug 01; 2(1-2):63-89. PubMed ID: 1726963
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.
    Li Y, O'Dell S, Walker LM, Wu X, Guenaga J, Feng Y, Schmidt SD, McKee K, Louder MK, Ledgerwood JE, Graham BS, Haynes BF, Burton DR, Wyatt RT, Mascola JR.
    J Virol; 2011 Sep 01; 85(17):8954-67. PubMed ID: 21715490
    [Abstract] [Full Text] [Related]

  • 26. Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.
    Hu G, Liu J, Roux KH, Taylor KA.
    J Virol; 2017 Aug 15; 91(16):. PubMed ID: 28539445
    [Abstract] [Full Text] [Related]

  • 27. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.
    Cale EM, Gorman J, Radakovich NA, Crooks ET, Osawa K, Tong T, Li J, Nagarajan R, Ozorowski G, Ambrozak DR, Asokan M, Bailer RT, Bennici AK, Chen X, Doria-Rose NA, Druz A, Feng Y, Joyce MG, Louder MK, O'Dell S, Oliver C, Pancera M, Connors M, Hope TJ, Kepler TB, Wyatt RT, Ward AB, Georgiev IS, Kwong PD, Mascola JR, Binley JM.
    Immunity; 2017 May 16; 46(5):777-791.e10. PubMed ID: 28514685
    [Abstract] [Full Text] [Related]

  • 28. An HIV-1 envelope immunogen with W427S mutation in CD4 binding site induced more T follicular helper memory cells and reduced non-specific antibody responses.
    Yu HT, Tian D, Wang JY, Guo CX, Li Y, Wang X, Li D, Zhang FM, Zhuang M, Ling H.
    PLoS One; 2014 May 16; 9(12):e115047. PubMed ID: 25546013
    [Abstract] [Full Text] [Related]

  • 29. Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign.
    Tran K, Poulsen C, Guenaga J, de Val N, Wilson R, Sundling C, Li Y, Stanfield RL, Wilson IA, Ward AB, Karlsson Hedestam GB, Wyatt RT.
    Proc Natl Acad Sci U S A; 2014 Feb 18; 111(7):E738-47. PubMed ID: 24550318
    [Abstract] [Full Text] [Related]

  • 30. Soluble mimetics of human immunodeficiency virus type 1 viral spikes produced by replacement of the native trimerization domain with a heterologous trimerization motif: characterization and ligand binding analysis.
    Pancera M, Lebowitz J, Schön A, Zhu P, Freire E, Kwong PD, Roux KH, Sodroski J, Wyatt R.
    J Virol; 2005 Aug 18; 79(15):9954-69. PubMed ID: 16014956
    [Abstract] [Full Text] [Related]

  • 31. Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies.
    Rusert P, Krarup A, Magnus C, Brandenberg OF, Weber J, Ehlert AK, Regoes RR, Günthard HF, Trkola A.
    J Exp Med; 2011 Jul 04; 208(7):1419-33. PubMed ID: 21646396
    [Abstract] [Full Text] [Related]

  • 32. Design of an Escherichia coli expressed HIV-1 gp120 fragment immunogen that binds to b12 and induces broad and potent neutralizing antibodies.
    Bhattacharyya S, Singh P, Rathore U, Purwar M, Wagner D, Arendt H, DeStefano J, LaBranche CC, Montefiori DC, Phogat S, Varadarajan R.
    J Biol Chem; 2013 Apr 05; 288(14):9815-9825. PubMed ID: 23430741
    [Abstract] [Full Text] [Related]

  • 33. An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site.
    Ahmed FK, Clark BE, Burton DR, Pantophlet R.
    Vaccine; 2012 Jan 20; 30(5):922-30. PubMed ID: 22142583
    [Abstract] [Full Text] [Related]

  • 34. Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.
    Julien JP, Lee JH, Cupo A, Murin CD, Derking R, Hoffenberg S, Caulfield MJ, King CR, Marozsan AJ, Klasse PJ, Sanders RW, Moore JP, Wilson IA, Ward AB.
    Proc Natl Acad Sci U S A; 2013 Mar 12; 110(11):4351-6. PubMed ID: 23426631
    [Abstract] [Full Text] [Related]

  • 35. Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.
    Chen L, Kwon YD, Zhou T, Wu X, O'Dell S, Cavacini L, Hessell AJ, Pancera M, Tang M, Xu L, Yang ZY, Zhang MY, Arthos J, Burton DR, Dimitrov DS, Nabel GJ, Posner MR, Sodroski J, Wyatt R, Mascola JR, Kwong PD.
    Science; 2009 Nov 20; 326(5956):1123-7. PubMed ID: 19965434
    [Abstract] [Full Text] [Related]

  • 36. An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies.
    Boliar S, Das S, Bansal M, Shukla BN, Patil S, Shrivastava T, Samal S, Goswami S, King CR, Bhattacharya J, Chakrabarti BK.
    PLoS One; 2015 Nov 20; 10(3):e0122443. PubMed ID: 25822521
    [Abstract] [Full Text] [Related]

  • 37. Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer.
    Liu L, Cimbro R, Lusso P, Berger EA.
    Proc Natl Acad Sci U S A; 2011 Dec 13; 108(50):20148-53. PubMed ID: 22128330
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Study of antibody repertoires to the CD4 binding site of gp120 of a Chinese HIV-1-infected elite neutralizer, using 454 sequencing and single-cell sorting.
    Li D, Wang Z, Ren L, Zhang J, Feng G, Hong K, Hao Y, Qi Z, Liang H, Shao Y.
    Arch Virol; 2016 Apr 13; 161(4):789-99. PubMed ID: 26671829
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.